David Copolov - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David Copolov

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

Psychiatry Research|December 3, 2015

Benefits of adjunctive N-acetylcysteine in a sub-group of clozapine-treated individuals diagnosed with schizophreniaOlivia M Dean, Serafino G Mancuso, Ashley I Bush, et al.

Biological Psychiatry|April 26, 2008

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trialMichael Berk, David Copolov, Olivia Dean, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 16, 2007

Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patientsSuzie Lavoie, Micah M Murray, Patricia Deppen, et al.

Pageof 5

Search research articles

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

Psychiatry Research|December 3, 2015

Benefits of adjunctive N-acetylcysteine in a sub-group of clozapine-treated individuals diagnosed with schizophreniaOlivia M Dean, Serafino G Mancuso, Ashley I Bush, et al.

Biological Psychiatry|April 26, 2008

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trialMichael Berk, David Copolov, Olivia Dean, et al.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 16, 2007

Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patientsSuzie Lavoie, Micah M Murray, Patricia Deppen, et al.

Pageof 5